Literature DB >> 21035443

Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing.

Motohisa Kawakatsu1, Seiji Kanno, Ting Gui, Zhibo Gai, Shunji Itoh, Hiroyuki Tanishima, Kosuke Oikawa, Yasuteru Muragaki.   

Abstract

Smad3 is an intracellular signaling molecule in the transforming growth factor β (TGF-β) pathway that serves as a regulator of chondrogenesis and osteogenesis. To investigate the role of the TGF-β/Smad3 signaling in the process of fracture healing, an open fracture was introduced in mouse tibiae, and the histology of the healing process was compared between wild-type (WT) and Smad3-null (KO) mice. In KO mice, the bone union formed more rapidly with less formation of cartilage in the callus and eventually the fracture was repaired more rapidly than in WT mice. Alkaline phosphatase staining showed that osteoblastic differentiation in the fracture callus was promoted in KO mice. Additionally, TRAP staining and the TUNEL assay revealed that the induction of osteoclasts and apoptotic cells was significantly promoted in the healing callus of KO mice. Sox9 expression clearly decreased at both mRNA and protein levels in the early stage of fracture in KO mice. In contrast, the expression of genes for osteogenesis and osteoclast formation increased from day 5 until day 14 post-fracture in KO mice compared to WT mice. From these results, we concluded that the loss of TGF-β/Smad3 signaling promoted callus formation by promoting osteogenesis and suppressing chondrogenesis, which resulted in faster fracture healing. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035443     DOI: 10.1016/j.yexmp.2010.10.011

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

1.  Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.

Authors:  Eva Grönroos; Isabel J Kingston; Anassuya Ramachandran; Rebecca A Randall; Pedro Vizán; Caroline S Hill
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

Review 2.  Local and targeted drug delivery for bone regeneration.

Authors:  Maureen R Newman; Danielle Sw Benoit
Journal:  Curr Opin Biotechnol       Date:  2016-04-08       Impact factor: 9.740

3.  Biglycan modulates angiogenesis and bone formation during fracture healing.

Authors:  Agnes D Berendsen; Emily L Pinnow; Azusa Maeda; Aaron C Brown; Nancy McCartney-Francis; Vardit Kram; Rick T Owens; Pamela G Robey; Kenn Holmbeck; Luis F de Castro; Tina M Kilts; Marian F Young
Journal:  Matrix Biol       Date:  2013-12-25       Impact factor: 11.583

4.  Acid bone lysates reduce bone regeneration in rat calvaria defects.

Authors:  Franz-Josef Strauss; Ulrike Kuchler; Reiko Kobatake; Patrick Heimel; Stefan Tangl; Reinhard Gruber
Journal:  J Biomed Mater Res A       Date:  2020-07-10       Impact factor: 4.854

Review 5.  How much do we know about the role of osteocytes in different phases of fracture healing? A systematic review.

Authors:  Man Huen Victoria Choy; Ronald Man Yeung Wong; Simon Kwoon Ho Chow; Meng Chen Li; Yu Ning Chim; Tsz Kiu Li; Wing Tung Ho; Jack Chun Yiu Cheng; Wing Ho Cheung
Journal:  J Orthop Translat       Date:  2019-08-08       Impact factor: 5.191

6.  MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head.

Authors:  Ligong Fu; Huawei Liu; Weijun Lei
Journal:  J Orthop Surg Res       Date:  2020-05-14       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.